![RJPS Journal Cover Page](../../../../files/rjps/cover/cover4.jpg)
RJPS Vol No: 14 Issue No: 2 eISSN: pISSN:2249-2208
Dear Authors,
We invite you to watch this comprehensive video guide on the process of submitting your article online. This video will provide you with step-by-step instructions to ensure a smooth and successful submission.
Thank you for your attention and cooperation.
1Department of Pharmaceutics, Krupanidhi College of Pharmacy, Bengaluru, Karnataka, India
2Dr. Preeti Karwa, Professor and Head of Department, Department of Pharmaceutics, Al-Ameen College of Pharmacy, Nr. Lalbaug Main Gate, Hosur Road, Bangalore, Karnataka, India.
3Department of Pharmaceutics, NITTE College of Pharmaceutical Sciences, Bengaluru, Karnataka, India
*Corresponding Author:
Dr. Preeti Karwa, Professor and Head of Department, Department of Pharmaceutics, Al-Ameen College of Pharmacy, Nr. Lalbaug Main Gate, Hosur Road, Bangalore, Karnataka, India., Email: aacp012018@gmail.com![CC BY NC 4.0 ICON](https://journalgrid.com/images/cc-by-nc.png)
Abstract
Background & Aim: Aspirin, a non-steroidal anti-inflammatory drug, has the potential to stimulate various dental stem cells and promotes regeneration of dental tissues. Polylactic glycolic acid (PLGA), a biocompatible and biodegradable polymer, has the potential to stimulate multiple processes, such as proliferation, osteogenic differentiation, initiation of mechanical support, and formation of three-dimensional niches for the growth of new tissue. Hence, this study aimed to identify the most effective formulation and process variables for developing aspirin polylactic glycolic acid microspheres using the Placket-Burman method.
Method: In the screening study, Placket-Burman screening was systematically employed to estimate all of the parameter effects and interactions. The microspheres were formulated using the double-emulsion solvent extraction method by varying various variables and performing statistical analysis. Eight independent variables were considered for screening with encapsulation efficiency as the dependent variable. These variables included, the volume of the internal phase of primary emulsion, solvent system (ethyl acetate: ethanol), homogenization time, stirring speed, emulsification time, flow rate, poly (vinyl alcohol) concentration, and PLGA concentration.
Results: Encapsulation efficiency varied between 50.11% and 88.98%. The concentration of PLGA and Poly (vinyl alcohol) and the volume of the internal phase were found to have a significant influence on encapsulation efficiency in the synthesis of Aspirin PLGA microsphere.
Conclusion: Among the eight independent variables assessed for screening, the concentrations of PLGA and poly(vinyl alcohol) and the volume of the internal phase were found to significantly impact the encapsulation efficiency in the formulation of aspirin PLGA microspheres.
Keywords
Downloads
-
1FullTextPDF
Article
Introduction
Aspirin (Acetyl Salicylic Acid, ASA), the wonder drug can regulate a variety of disease conditions and has the potential to stimulate multiple dental stem cells, thereby promoting the regeneration of dentin and the periodontal ligament.1,2 According to the study conducted by Rahman et al., aspirin has the capacity to stimulate the periodontal ligament stem cells and helps in the stimulation of growth factors like fibroblast growth factor (FGF), Vascular Endothelial Growth Factor A (VEGFA) and Bone Morphogenetic Protein (BMP) and aids in osteogenic potential.2 The study also revealed that aspirin at concentration 1000 µM is capable of enhancing the osteogenic potential, and is non-cytotoxic to the stem cells. At this dose, the drug is capable of enhancing the activation of biological functions, cellular signalling and cellular growth, proliferation and differentiation. These findings strongly imply that aspirin has excellent potential in the management of several dental problems for which there is no defined treatment strategy.
Furthermore, different biomaterials (such as chitosan, PLGA, alginate, etc.) offer physical, chemical, and biological environments to control cell responses for growth and differentiation.3 They are efficient carriers of nutrients, oxygen, and waste and thus are a platform for cell growth and development of new tissues. This three-dimensional structure substitutes for the extracellular matrix, which releases the growth factor involved in neo-tissue formation.4 The incorporation of bioactive molecules improves the interaction with cells and enhances migration, differentiation, and proliferation of dental cells, consequently enhancing tissue regeneration.3,4 According to previous studies, polylactic glycolic acid (PLGA) can promote proliferation, osteogenic differentiation, initiation of mechanical support, and formation of three-dimensional niches for new tissue growth, as well as inhibit the early down-growth of gingival epithelium and connective tissues.5,6 Consequently, the denuded root surface can be repopulated by regenerative cells. Various researchers have formulated various forms of PLGA like films, microspheres, nanoparticle and scaffolds, to incorporate the biological markers for the regeneration of various dental tissue structures.7-11 Therefore, it is necessary to investigate the therapeutic effectiveness of aspirin by designing and developing a novel PLGA formulation.
However, the effective development of appropriate formulations necessitates taking into account several variables that have an impact on the formulation's performance, such as the physicochemical properties of the drugs and excipients, their composition, and various manufacturing processes.11 These parameters can be screened by selecting a suitable experimental design. Therefore, the Plackett-Burman experimental design facilitates the determination and assessment of independent variables that influence the formulation response by mathematically calculating the significance of a large number of factors in one experiment.12 In the current study, the Plackett-Burman design was used to examine the effects of process parameters on the synthesis of aspirin-loaded PLGA microspheres, and significant process parameters that primarily influence encapsulation efficiency were identified.
Materials and Methods
Aspirin and PLGA (75:25) were a gift sample from Alta Labs, and Evonik, India. Ethyl acetate (S.D. fine chemicals, India), Poly (vinyl alcohol) (Mw 1,30,000, 18-88% hydrolyzed, Sigma-Aldrich) were procured. Analytical grade solvents were used.
Formulation of Aspirin loaded PLGA microsphere
The double-emulsion solvent extraction method was adopted to formulate the aspirin-PLGA microsphere.12,13 PLGA and aspirin were dissolved in the organic phase (acetate-ethanol solvent system), and an aqueous solution was injected. The mixture was emulsified at varying speeds and different time interval using a homogenizer (Kinematica Polytron™ PT2100) to produce a waterin-oil emulsion (w/o). The resulting w/o emulsion was injected (at different flow rates) into a polyvinyl alcohol solution (PVA, different concentrations) and emulsified at room temperature to form a W/O/W emulsion. The formed microspheres were hardened using the solvent extraction method by dissolving the excess aqueous phase and stirring in a magnetic stirrer overnight. Finally, the samples were centrifuged (15,000 rpm for 10 min) and washed continuously to separate the microspheres. Isolated microspheres were screened and optimized using suitable statistical experimental method.
Experimental design and analysis
In this study, the Plackett-Burman screening design was used to investigate the effects of four process parameters, including homogenization time (min), stirring speed (rpm), emulsification time (min), and flow rate (mL/min), as well as four formulation variables such as PVA concentration (%), volume of the internal phase of the primary emulsion (mL), solvent system (ethyl acetate: ethanol), and PLGA concentration (%) on the encapsulation efficiency of the microspheres. Design-Expert® Version 12 was used to devise a 12- run, eight-factor Plackett-Burman screening design (Stat-Ease Inc., Minneapolis, USA). Factors were assigned a "high" and a "low" level, and are presented in Table 1. To estimate the variance (experimental error) of an effect, insignificant dummy variables were assigned in addition to the variables of real interest. These variables were not assigned any values.
Determination of Encapsulation Efficiency
The difference between the amount of aspirin added during formulation and the amount of unentrapped drug in the external phase following formulation was used to calculate the encapsulated efficiency (EE). The aspirin that was not encapsulated was checked in the supernatant by UV spectroscopy at 277 nm after centrifugation of the formed suspension for 10 minutes at 15,000 rpm.9
Results and Discussion
Screening Design
Screening designs aim to identify formulation variables that can be modified or eliminated for further studies. Plackett-Burman screening was used to consider the main effects among the eight independent variables. The variable levels were considered based on preliminary experiments and data not shown.
The response of the encapsulation efficiency obtained is recorded in Table 2, and varies between 50.11% and 88.98%.
Data were transferred into Design Expert (12.0) software, and a linear model for the encapsulation efficiency of aspirin in terms of coded factors was developed as shown in equation.
Encapsulation efficiency = 39.58167-0.730667A-0.006 993B+4.29333C-1.72500D+0.031893E-1.2F+ 17.42G-0.295111H
From the above equation and the model's P-value, F-value, mean square, and R2 (from the ANOVA shown in Table 3), it can be deduced that the PVA concentration, volume of the internal phase, and PLGA concentration have a significant impact on encapsulation efficiency. The statistical significance of the Plackett Burman design can also be examined using standardized Pareto charts (Figure 2), which represent the estimated effects of the parameters on the response. The t-value of Student’s t-test, which is represented by the length of the bars, is proportional to the absolute value of the estimated effects divided by the standard error.
Furthermore, improved encapsulation efficiency due to PLGA and PVA concentrations may be due to increased viscosity, which can prevent the drug from diffusing from the organic phase.14
In addition to this positive effect of PLGA concentration, larger particles may be formed when PLGA concentration is increased. Hence, it provides a sufficient surface for aspirin entrapped.14,15
The second prominent effect is the PVA concentration, which accounts for an increase in viscosity due to concentration, preventing the outward diffusion of the drug from the internal aqueous phase and better stabilization of the double emulsion at higher PVA concentrations.10
Conclusion
The Plackett-Burman screening design was devised to study the favorable effect parameters on the encapsulation efficiency of aspirin-loaded PLGA microspheres. Twelve experimental runs were conducted to establish the relationship between the factors and the response. PLGA concentration, volume of the internal phase, and PVA concentration, significantly affected encapsulation efficiency. The screened factors were used for further optimization of aspirin-PLGA microspheres.
Conflict of interest
None
Supporting File
References
- Dixon C. Aspirin 'can RE-GROW rotting teeth by being used to fill cavities'. [newspaper on the Internet]. 2017 Sep 7 [cited 2019 Dec 08] Available from: www.express.co.uk/life-style/health/851045/ aspirin-tooth-decay-dentist-dental-cavities-teeth
- Rahman AF, Mohd Ali J, Abdullah M, et al. Aspirin Enhances osteogenic potential of Periodontal Ligament Stem Cells (PDLSCs) and modulates the expression profile of growth factor–associated genes in PDLSCs. J Periodontol 2016;87(7): 837-847
- Moussa DG, Aparicio C. Present and future of tissue engineering scaffolds for dentin-pulp complex regeneration. J Tissue Eng Regen Med 2019;13(1):58‐75.
- Zhang L, Morsi Y, Wang Y, et al. Review scaffold design and stem cells for tooth regeneration. Jpn Dent Sci Rev 2013;49(1):14-26.
- El-Backly RM, Massoud AG, El-Badry AM, et al. Regeneration of dentine/pulp-like tissue using a dental pulp stem cell/poly(lactic-co-glycolic) acid scaffold construct in New Zealand white rabbits. Aust Endod J 2008;34(2):52‐67.
- Yoshimoto I, Sasaki JI, Tsuboi R, et al. Development of layered PLGA membranes for periodontal tissue regeneration. Dent Mater 2018;34(3):538-550.
- Park JK, Yeom J, Oh EJ, et al. Guided bone regeneration by poly(lactic-co-glycolic acid) grafted hyaluronic acid bi-layer films for periodontal barrier applications. Acta Biomaterialia 2009;5(9): 3394-403.
- Jamal T, Rahman MA, Mirza MA, et al. Formulation, antimicrobial and toxicity evaluation of Bioceramic based ofloxacin loaded biodegradable microspheres for periodontal infection. Curr Drug Deliv 2012;9(5):515-526.
- Kashi TSJ, Eskandarion S, Esfandyari-Manesh M, et al. Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/ water ion pairing method. Int J Nanomedicine 2012;7:221-34.
- Jones AA, Buser D, Schenk R, et al. The effects of rhBMP-2 around endosseous implants with and without membranes in the canine model. J Periodontol 2006;77(7):1184-93.
- Kodonas K, Gogos C, Papadimitriou S, et al. Experimental formation of dentin-like structure in the root canal implant model using cryopreserved swine dental pulp progenitor cells. J Endod 2017;38(7):913-9.
- Kenari HS, Alinejad Z, Imani M, et al. Effective parameters in determining cross-linked dextran microsphere characteristics: screening by Plackett-Burman design-of-experiments. J Microencapsul 2013;30(6):599-611.
- Thomas L, Karwa P, Devi VK. Formulation and evaluation of Aspirin-PLGA microsphere for the dental stem cell stimulation. Indian J. Pharm. Educ. Res 2023;57(1s):s52-s62.
- Tefas LR, Tomuţă I, Achim M, et al. Development and optimization of quercetin-loaded plga nanoparticles by experimental design. Clujul Med 2015;88(2):214-223.
- Kumar MNVR, Bakowsky U, Lehr CM. Preparation and characterization of cationic PLGA nanospheres as DNA carriers. Biomaterials 2004;25(10):1771-1777.